 Healthcare companies are reaping the benefits of a global swine flu pandemic, brightening what might otherwise have been a dismal third quarter
and bringing new focus on the market for vaccines. Large European pharmaceutical companies are reporting windfall sales from flu drugs and H1N1
vaccines.
Small biotechs are winning fresh attention from investors and governments looking for quick, less expensive ways of making flu vaccines to protect
their populations. And diagnostic companies have been growing revenues as doctors order more flu tests.
"Pretty much everyone who does something in influenza in has gained from it," said Hedwig Kresse, an infectious diseases analyst at Datamonitor in
London. Please visit the link provided for the complete story.
Let's take one example:
On Friday the U.S. Food and Drug Administration issued an emergency use authorization for an experimental new drug called peramivir, made by
Biocryst Pharmaceuticals Inc and licensed to Shionogi & Co Ltd.
The authorization allows the intravenous drug to be used in hospitalized patients who cannot take pills or inhale Relenza or when Tamiflu or Relenza
do not seem to be helping. Please visit the link provided for the complete story.
Sounds like a total surprise for investors!
But not for everyone
Banks are so last season. Get with it. Pharmaceuticals are hip.
So what if the banks go down? At least the PTB/Goldman Sachs stockies now have somewhere to store their hard-earned cash.
OK, it may be on the back of mass/?forced? vaccinations, but hey, it's all for your good.
Ethical investments, anyone?..
edited title / kj
[edit on 31/10/2009 by kosmicjack]
|
I couldnt sgree more pause. Big pharma is the new wave of money, and Obamas recent "OMG H1N1 is a national emergency" just goes to prove it. If you
dont feel perfect all the time, Big Pharma is there with a med to fix you right up.
|
reply to post by dredz
The rabbit hole is opening up:
The New York Times
Less than two months after ascending to the United States Senate, Barack Obama bought more than $50,000 worth of stock in two speculative companies
whose major investors included some of his biggest political donors.
One of the companies was a biotech concern that was starting to develop a drug to treat avian flu. In March 2005, two weeks after buying about $5,000
of its shares, Mr. Obama took the lead in a legislative push for more federal spending to battle the disease.
More at Source
(Acknowledgements to Stormdancer777 for finding the above.)
The whole thing makes your head swim:
There can be little doubt there's an ocean of money to be made from the epidemic/pandemic. The question is: exactly who's pockets will it be flowing
into?
|
This is a good topic to investigate further, IMHO, it is all linked together.
.
|
